With the costs of taking a drug successfully to market now spiralling to $2.6 billion, the critical need to reduce cycle time and improve accuracy in target identification and validation is clear.
In-depth consultation with your peers across global pharma & biotech has shown that the latest in machine learning, data mining, predictive informatics & advanced analytics are key to powering drug discovery and repurposing.
This research has culminated in the launch of Discovery Informatics & Analytics Summit 2016, the only industry event focused on the practical application of models and informatics specifically for drug discovery and repurposing.
So, do you want to find out how AstraZeneca, Berg, Janssen or GSK are accelerating drug discovery?
The event programme showcases unparalleled access to case studies and discussion groups led by these organisations to find out how to harness the latest in informatics analytics to:
Unlock scientific insights from pre-clinical data sets
Power drug discovery and repurposing from archived data
Harness OMICs to cut through validation barriers
Understand compound performance and viability through simulation
Use text mining and image analysis techniques to delve deeper into current research
Standardise complex data sets and promote translational medicine to deliver new insights
Join your peers at this launch event to ensure you have insight into the latest industry leading models and applications to assist you in accelerating discovery cycle time for your organisation.
To secure your place today, be sure to register online now at www.discovery-informatics.com, call +44 (0) 800 098 8489 or email email@example.com
For more information:
Last updated on: 01/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.